Advertisement
Screener

Cogent Biosciences, Inc. (COGT) Net Margin

Cogent Biosciences, Inc. (COGT) Net Margin

  • 2020-09-30: Net Margin -16020.19%.
  • 2020-06-30: Net Margin -1400.19%.
  • 2020-03-31: Net Margin -86.67%.
  • 2019-12-31: Net Margin 15.02%.

Complete source-backed net margin history.

Available history
2017-06-30 to 2020-12-31
Data captured

Historical Net Margin

DateNet Margin
2020-09-30-16020.19%
2020-06-30-1400.19%
2020-03-31-86.67%
2019-12-3115.02%
2019-09-30-1168.92%
2019-06-30-335.12%
2019-03-31-382.93%
2018-12-31-226.18%
2018-09-30-497.70%
2018-06-30-541.60%
2018-03-31-303.38%
2017-12-31-315.12%
2017-09-30-300.30%
2017-06-30-282.01%

Annual Net Margin

DateNet Margin
2020-12-31-950.43%
2019-12-31-141.49%
2018-12-31-354.76%
2017-12-31-304.93%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Gossamer Bio, Inc. (GOSS)United States$5.355B-0.65
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76
PTC THERAPEUTICS, INC. (PTCT)United States$5.199B-177.07
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Dianthus Therapeutics, Inc. /DE/ (DNTH)United States$5.082B-27.79
Erasca, Inc. (ERAS)United States$5.073B-19.96
Veradermics, Inc (MANE)United States$4.839B
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
Liquidia Corp (LQDA)United States$6.347B51.23